Molecular Chaperones in Neurodegenerative Diseases: Mechanistic Role and Therapeutic Potential

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biophysics: Structure, Dynamics, and Function".

Deadline for manuscript submissions: 31 March 2026 | Viewed by 16

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33612, USA
Interests: drug discovery; molecular chaperone proteins; neurodegenerative & other diseases

Special Issue Information

Dear Colleagues,

Molecular chaperones regulate multiple aspects of protein processing in normal and disease conditions. In particular, during normal conditions, heat shock proteins (Hsps), such as molecular chaperones Hsp90 and Hsp70, are involved in protein folding and degradation. In abnormal conditions, mutation or posttranslational modification of a disease-associated protein leads to changes in chaperone complex processing, protein misfolding, and aggregation. A better understanding of the role of these chaperones and their co-chaperones in neurodegenerative diseases will provide mechanistic insights into disease progression and potentially lead to new therapeutic options. The focus of this special issue is on the mechanistic and therapeutic potential of molecular chaperones in Alzheimer's disease, Parkinson’s disease, Huntington's disease, Amyotrophic Lateral Sclerosis, and other neurodegenerative disorders. 

Dr. Umesh Kumar Jinwal
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • molecular chaperones
  • neurodegenerative diseases
  • Hsp90
  • Hsp70
  • Alzheimer's Disease
  • Parkinson’s Disease
  • Huntington's disease
  • amyotrophic lateral sclerosis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop